Advisory Fee Shares to B. Riley Securities
Company: Core Scientific
The claim, verbatim
386,697 shares of Common Stock issued to BRS as an advisory fee in connection with the execution of amended and restated bridge promissory notes
Source (primary)
Core Scientific 424B3 filed 2022-10-27 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “386,697 shares (the "Advisory Fee Shares"... of Common Stock that we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document identifies 386,697 Advisory Fee Shares issued to BRS as an advisory fee tied to the bridge notes.
Confirmed in the source:
- 386,697 shares of Common Stock were issued to BRS as an advisory fee
- The fee was in connection with execution of the amended and restated bridge promissory notes
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522270235/d395956d424b3.htm) in full (8,915 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-27
Quote: “386,697 shares (the "Advisory Fee Shares"... of Common Stock that we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022”